Medical Communications

The Spring 2017 edition of Pharmafile, our bi-annual market intelligence report for the life sciences industry, is available to read …

Sanofi has entered an ever-growing list of pharmaceutical companies that are pledging to limit the levels of their price increases …

Kymab, a therapeutic antibody company based in Cambridge, UK, has announced that it has appointed Dr Sonia Quaratino as its …

About Global Pricing Innovations (GPI)

About Global Pricing Innovations (GPI)

With clinical practice marching towards a more precision-oriented methodology, assessment of treatment efficacy is undergoing a transformation. Matt Fellows explores the …

NICE has announced, in an Appraisal Consultation Document, that it is not able to recommend Orexigen’s Mysimba as a weight …

NHS Providers, the membership organisation and trade association for the NHS, has laid a stark warning at the door of …

It’s Friday again, and today marks the press date of the latest edition of Pharmafile, our bi-annual life sciences market …

Following NICE’s decision rejecting Pfizer’s breast cancer therapy Ibrance (palbociclib) for use on the NHS, the manufacturer has announced that …

Regulus seemed to be in a good place just last year as its lead drug candidate performed well in a …

Johnson & Johnson has suffered another defeat in a lawsuit against its talcum powder product. The latest case stands as …

GSK has announced that it will invest $139 million into increasing production capacity at its Rockville, Maryland, site. The manufacturing …

The European Commission has issued a warning to pharmaceutical firms in the UK over the validity of current and future …

The WHO has announced that it will launch a project to prequalify biosimilar medicines for the treatment of certain cancers. …